24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Share this page From AI to CSR: leading the conversation at the Virtual 2022 European Meeting of ISMPP The changing publications landscape, cross-functional collaboration and artificial intelligence (AI) were all on the agenda at the Virtual 2022 European Meeting of ISMPP, as Oxford PharmaGenesis led conversations on some of the most compelling issues affecting the…
Together we can explore the latest opportunities in publications, medical affairs, informatics and patient engagement.
If you are ready to explore new frontiers, Oxford PharmaGenesis is ready to help.
Did you know? Ten unbeatable reasons to explore a career with Oxford PharmaGenesis in 2022 It’s a new year, and a time when many people reflect on whether their role is providing the opportunities, enjoyment and sense of purpose that they deserve. If this sounds familiar, and you are looking for something new, then a…
Oxford PharmaGenesis is proud to sponsor the CISCRP December 2021 Clinical Trials supplement, which raises awareness of rare diseases and neurology, and celebrates the millions of people who volunteer for clinical trials each year.
Every year during the festive season, Oxford PharmaGenesis donates to a charity aligned with our company mission to help patients in areas of unmet medical need. This year, Oxford PharmaGenesis is donating to UNICEF to help fund the delivery of more than 150 000 doses of the COVID-19 vaccines to some of the communities that…
This October, Oxford PharmaGenesis has been marking Global Diversity Awareness Month with a programme of educational and awareness-raising activities coordinated by and for our colleagues.
